{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:31:40Z","timestamp":1761863500953},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s12253-015-0029-2","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T18:42:24Z","timestamp":1451328144000},"page":"549-554","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Performance of APTIMA Human Papillomavirus (HPV) 16 18\/45 mRNA Genotyping Testing for the Detection of Cervical Intraepithelial Neoplasia 3 (CIN3) or Cancer in a Select Group of Chinese Women"],"prefix":"10.1007","volume":"22","author":[{"given":"Yan-li","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527","journal-title":"N Engl J Med"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","volume":"103","author":"M Schiffman","year":"2001","unstructured":"Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2001) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:368\u2013383","journal-title":"J Natl Cancer Inst"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL (2015) Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 136:189\u2013197","journal-title":"Gynecol Oncol"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJ, Arbyn M et al (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383:524\u2013532","journal-title":"Lancet"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/LGT.0b013e318285437b","volume":"17","author":"HA Katki","year":"2013","unstructured":"Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T et al (2013) Five-year risk of CIN3+ and cervical cancer for women who test Pap-negative, but are HPV-positive. J Low Genit Tract Dis 17:S56\u2013S63","journal-title":"J Low Genit Tract Dis"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","volume":"137","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Am J Clin Pathol 137:516\u2013542","journal-title":"Am J Clin Pathol"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","volume":"121","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M et al (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 121:829\u2013846","journal-title":"Obstet Gynecol"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","volume":"21","author":"M Arbyn","year":"2010","unstructured":"Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N et al (2010) European Guidelines for Quality Assurance in cervical cancer screening. Second edition\u2014summary document. Ann Oncol 21:448\u2013458","journal-title":"Ann Oncol"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1309\/XFUCPP6M5XUA94B8","volume":"120","author":"P Cremoux de","year":"2003","unstructured":"de Cremoux P, Coste J, Sastre-Garau X, Thioux M, Bouillac C, Labbe S et al (2003) Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology. Am J Clin Pathol 120:492\u2013499","journal-title":"Am J Clin Pathol"},{"key":"29_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","volume":"95","author":"ME Sherman","year":"2003","unstructured":"Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG et al (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95:46\u201352","journal-title":"J Natl Cancer Inst"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S et al (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119:1095\u20131101","journal-title":"Int J Cancer"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","volume":"100","author":"G Ronco","year":"2008","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del MA et al (2008) Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100:492\u2013501","journal-title":"J Natl Cancer Inst"},{"key":"29_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2011.02.018","volume":"121","author":"M Sideri","year":"2011","unstructured":"Sideri M, Igidbashian S, Boveri S, Radice D, Casadio C, Spolti N et al (2011) Age distribution of HPV genotypes in cervical intraepithelial neoplasia. Gynecol Oncol 121:510\u2013513","journal-title":"Gynecol Oncol"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R et al (2007) Human papillo-mavirus type distribution in invasive cervical cancer and high-grade cervicallesions: a meta-analysis update. Int J Cancer 121:621\u2013632","journal-title":"Int J Cancer"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927\u2013935","journal-title":"Int J Cancer"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos\u00e9 S, Franceschi S et al (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131:2349\u20132359","journal-title":"Int J Cancer"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1016\/j.vaccine.2006.05.026","volume":"24","author":"GM Clifford","year":"2006","unstructured":"Clifford GM, Franceschi S, Diaz M, Mu\u00f1oz N, Villa LL (2006) HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24:S326\u2013S334","journal-title":"Vaccine"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcv.2015.04.004","volume":"67","author":"R Luttmer","year":"2015","unstructured":"Luttmer R, Berkhof J, Dijkstra MG, van Kemenade FJ, Snijders PJ, Heideman DA et al (2015) Comparing triage algorithms using HPV DNA genotyping, HPV E7mRNA detection and cytology in high-risk HPV DNA-positive women. J Clin Virol 67:59\u201366","journal-title":"J Clin Virol"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(02)09463-1","volume":"360","author":"AT Lorincz","year":"2002","unstructured":"Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S et al (2002) Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228\u2013229","journal-title":"Lancet"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajog.2004.05.018","volume":"191","author":"PE Castle","year":"2004","unstructured":"Castle PE, Schiffman M, Wheeler CMALTS group (2004) Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer. Am J Obstet Gynecol 191:1590\u20131597","journal-title":"Am J Obstet Gynecol"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","volume":"339","author":"PE Castle","year":"2009","unstructured":"Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M et al (2009) Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 339:b2569\u2013b2581","journal-title":"BMJ"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2334-10-326","volume":"10","author":"AV Ramanakumar","year":"2010","unstructured":"Ramanakumar AV, Goncalves O, Richardson H, Tellier P, Ferenczy A, Coutlee F et al (2010) Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis 10:326\u2013337","journal-title":"BMC Infect Dis"},{"key":"29_CR24","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/ijc.23012","volume":"121","author":"PE Gravitt","year":"2007","unstructured":"Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A et al (2007) High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121:2787\u20132793","journal-title":"Int J Cancer"},{"key":"29_CR25","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.21477","volume":"118","author":"R Flores","year":"2006","unstructured":"Flores R, Papenfuss M, Klimecki WT, Giuliano AR (2006) Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 118:1187\u20131193","journal-title":"Int J Cancer"},{"issue":"79","key":"29_CR26","first-page":"e1","volume":"201","author":"S Wanram","year":"2009","unstructured":"Wanram S, Limpaiboon T, Leelayuwat C, Yuenyao P, Guiney DG, Lulitanond V et al (2009) The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. Am J Obstet Gynecol 201(79):e1\u2013e7","journal-title":"Am J Obstet Gynecol"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1111\/j.1582-4934.2012.01631.x","volume":"16","author":"CE Depuydt","year":"2012","unstructured":"Depuydt CE, Criel AM, Benoy IH, Arbyn M, Vereecken AJ, Bogers JJ (2012) Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med 16:3096\u20133104","journal-title":"J Cell Mol Med"},{"key":"29_CR28","author":"CE Depuydt","year":"2015","unstructured":"Depuydt CE, Jonckheere J, Berth M, Salembier GM, Vereecken AJ, Bogers JJ (2015) Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections. Cancer Med. doi: 10.1002\/cam4.473","journal-title":"Cancer Med"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1309\/BA43HMCAJ26VWQH3","volume":"122","author":"PE Castle","year":"2004","unstructured":"Castle PE, Wheeler CM, Solomon D, Schiffman M, Peyton CL, ALTS Group (2004) Interlaboratory reliability of hybrid capture 2. Am J Clin Pathol 122:238\u2013245","journal-title":"Am J Clin Pathol"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-015-0029-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-015-0029-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-015-0029-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:39:31Z","timestamp":1559457571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-015-0029-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s12253-015-0029-2","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}